Breaking News Instant updates and real-time market news.

EW

Edwards Lifesciences

$141.95

-1.44 (-1.00%)

16:32
10/15/18
10/15
16:32
10/15/18
16:32

Edwards Lifesciences initiated with an Underweight at Barclays

Target $143.

  • 23

    Oct

EW Edwards Lifesciences
$141.95

-1.44 (-1.00%)

10/09/18
SBSH
10/09/18
NO CHANGE
SBSH
Citi more selective on Medical Device stocks into Q3 results
Citi analyst Amit Hazan is "much more selective than usual" on Medical Device stocks into the Q3 earnings season. While easier comps should bring "strong and stable" Q3 organic sales growth, recent currency volatility will limit both earnings upside and guidance raises, Hazan tells investors in a research note. He sees only Boston Scientific (BSX) and Intuitive Surgical (ISRG) shares moving higher on earnings reports. The analyst expects volatility in both Becton Dickinson (BDX) and Varian Medical (VAR), but would be an "aggressive" buyer of the stocks on any post-earnings weakness. Hazan is also more cautious on names like Edwards Lifesciences (EW), Baxter (BAX), and Zimmer Biomet (ZBH) into the Q3 prints.
10/09/18
ADAM
10/09/18
NO CHANGE
Target $177
ADAM
Buy
Edwards Lifesciences weakness a buying opportunity, says Canaccord
Canaccord analyst Jason Mills said the recent weakness in Edwards Lifesciences is a compelling buying opportunity. The analyst said it remains his top large-cap stock, which enjoys a favorable setup through the Partner 3 low-risk data in March 2019. He also noted the positive data release on the CENTERA U.S. pivotal trial as well as its positioning and strategy in the TAVR space. Mills reiterated his Buy rating and $177 price target on Edwards Lifesciences shares.
10/02/18
BOFA
10/02/18
DOWNGRADE
Target $180
BOFA
Neutral
Edwards Lifesciences downgraded to Neutral from Buy at BofA/Merrill
BofA Merrill Lynch analyst Bob Hopkins downgraded Edwards Lifesciences to Neutral from Buy, primarily due to valuation. Only aggressive assumptions about TAVR market growth and Mitral would suggest real upside to consensus estimates, Hopkins tells investors. Additionally, it remains his view that Edwards is more likely than not to remain independent, added Hopkins, who raised his price target on the stock to $180 from $170 to account for higher valuations in the medical technology sector.
10/02/18
GUGG
10/02/18
DOWNGRADE
GUGG
Neutral
Edwards Lifesciences downgraded to Neutral from Buy at Guggenheim
Guggenheim downgraded Edwards Lifesciences to Neutral citing valuation.

TODAY'S FREE FLY STORIES

FMS

Fresenius Medical

$32.21

-2.05 (-5.98%)

06:03
10/23/19
10/23
06:03
10/23/19
06:03
Downgrade
Fresenius Medical rating change  »

Redburn downgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

KSS

Kohl's

$52.96

1.72 (3.36%)

06:03
10/23/19
10/23
06:03
10/23/19
06:03
Downgrade
Kohl's rating change  »

Kohl's downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

TMO

Thermo Fisher

$280.89

-2.56 (-0.90%)

06:03
10/23/19
10/23
06:03
10/23/19
06:03
Earnings
Thermo Fisher reports Q3 adj. EPS $2.94, consensus $2.87 »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 06

    Nov

  • 02

    Dec

  • 07

    Dec

ING

ING Group

$11.52

-0.04 (-0.35%)

06:03
10/23/19
10/23
06:03
10/23/19
06:03
Downgrade
ING Group rating change  »

ING Group downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

OC

Owens Corning

$63.41

-0.055 (-0.09%)

06:02
10/23/19
10/23
06:02
10/23/19
06:02
Hot Stocks
Owens Corning provides 2019 outlook »

"The company's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

REZI

Resideo

$15.17

0.03 (0.20%)

06:02
10/23/19
10/23
06:02
10/23/19
06:02
Downgrade
Resideo rating change  »

Resideo downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OC

Owens Corning

$63.41

-0.055 (-0.09%)

06:01
10/23/19
10/23
06:01
10/23/19
06:01
Earnings
Owens Corning reports Q3 adjusted EPS $1.63, consensus $1.50 »

Reports Q3 revenue $1.9B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

ANTM

Anthem

$260.28

7.12 (2.81%)

06:01
10/23/19
10/23
06:01
10/23/19
06:01
Earnings
Anthem raises FY19 adjusted EPS view to greater than $19.40 per share »

Prior view was greater…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

ANTM

Anthem

$260.28

7.12 (2.81%)

06:00
10/23/19
10/23
06:00
10/23/19
06:00
Earnings
Anthem reports Q3 adjusted EPS $4.87, consensus $4.82 »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

PPL

PPL Corp.

$32.74

0.09 (0.28%)

05:57
10/23/19
10/23
05:57
10/23/19
05:57
Downgrade
PPL Corp. rating change  »

PPL Corp. downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

  • 10

    Nov

  • 10

    Nov

  • 12

    Nov

KO

Coca-Cola

$53.87

-0.37 (-0.68%)

05:56
10/23/19
10/23
05:56
10/23/19
05:56
Upgrade
Coca-Cola rating change  »

Coca-Cola upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STOK

Stoke Therapeutics

$23.02

0.47 (2.08%)

05:55
10/23/19
10/23
05:55
10/23/19
05:55
Conference/Events
Stoke Therapeutics management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

WU

Western Union

$24.25

-0.1 (-0.41%)

05:29
10/23/19
10/23
05:29
10/23/19
05:29
Hot Stocks
Western Union announces new partners in Asia »

Western Union further…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

  • 31

    Oct

LNG

Cheniere Energy

$63.88

0.15 (0.24%)

05:28
10/23/19
10/23
05:28
10/23/19
05:28
Upgrade
Cheniere Energy rating change  »

Cheniere Energy upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

THLEF

Thales

$0.00

(0.00%)

05:27
10/23/19
10/23
05:27
10/23/19
05:27
Downgrade
Thales rating change  »

Thales downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KIM

Kimco Realty

$21.40

0.17 (0.80%)

05:26
10/23/19
10/23
05:26
10/23/19
05:26
Downgrade
Kimco Realty rating change  »

Kimco Realty downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 11

    Nov

  • 12

    Nov

  • 12

    Nov

ROIC

Retail Opportunity

$18.94

0.025 (0.13%)

05:26
10/23/19
10/23
05:26
10/23/19
05:26
Upgrade
Retail Opportunity rating change  »

Retail Opportunity…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 11

    Nov

ING

ING Group

$11.52

-0.04 (-0.35%)

05:25
10/23/19
10/23
05:25
10/23/19
05:25
Upgrade
ING Group rating change  »

ING Group upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

SWSDF

Swiss Life

$0.00

(0.00%)

05:24
10/23/19
10/23
05:24
10/23/19
05:24
Downgrade
Swiss Life rating change  »

Swiss Life downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LRAD

LRAD Corporation

$3.35

-0.1 (-2.90%)

, GNSS

Genasys

$3.35

-0.1 (-2.90%)

05:22
10/23/19
10/23
05:22
10/23/19
05:22
Hot Stocks
LRAD Corporation announces rebranding to 'Genasys', new symbol 'GNSS' »

LRAD Corporation…

LRAD

LRAD Corporation

$3.35

-0.1 (-2.90%)

GNSS

Genasys

$3.35

-0.1 (-2.90%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRWD

Crowdstrike

$46.15

-1.1 (-2.33%)

05:21
10/23/19
10/23
05:21
10/23/19
05:21
Initiation
Crowdstrike initiated  »

Crowdstrike initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

FMS

Fresenius Medical

$32.21

-2.05 (-5.98%)

05:20
10/23/19
10/23
05:20
10/23/19
05:20
Downgrade
Fresenius Medical rating change  »

Fresenius Medical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

UXIN

Uxin

$2.72

0.07 (2.64%)

05:19
10/23/19
10/23
05:19
10/23/19
05:19
Downgrade
Uxin rating change  »

Uxin downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNAP

Snap

$14.00

-0.58 (-3.98%)

05:18
10/23/19
10/23
05:18
10/23/19
05:18
Upgrade
Snap rating change  »

Snap upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

IRBT

iRobot

$53.88

-1.82 (-3.27%)

05:17
10/23/19
10/23
05:17
10/23/19
05:17
Recommendations
iRobot analyst commentary  »

iRobot price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 13

    Nov

  • 09

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.